Skip to content

13F-HR filed by Ally Bridge Group (NY) LLC

Ally Bridge Group (NY) LLC filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 31 holding rows worth $340,097,000.

Accession
0000950123-21-015123
Filed
2021-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A holdings report, 31 entries on the cover page, a total value of $340,097,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $340,097,000 with VALUE read as thousands by filing date, 13F file number 028-20834. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerFan Yu 028-20833

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NATERA INC COM632307104Stock268,000$29,866,000thousands by filing date
SPDR SERIES TRUST78464A950PUT200,000$25,142,000thousands by filing dateput
REPLIGEN CORP COM759916109Stock70,000$20,229,000thousands by filing date
ARVINAS INC04335A105COM210,000$17,258,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM95,000$16,806,000thousands by filing date
NUVATION BIO INC COM CL A67080N101Stock1,660,947$16,510,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM270,000$16,003,000thousands by filing date
SYROS PHARMACEUTICALS INC87184Q107COM3,439,895$15,376,000thousands by filing date
VIRIDIAN THERAPEUTICS INC92790C104COM904,978$14,887,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock1,175,000$14,770,000thousands by filing date
IDEAYA BIOSCIENCES INC COM45166A102Stock575,940$14,681,000thousands by filing date
COGENT BIOSCIENCES INC19240Q201COM1,622,591$13,646,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM406,986$10,036,000thousands by filing date
SOMALOGIC INC83444K105COM800,000$9,912,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U906CALL300,000$9,888,000thousands by filing datecall
NAUTILUS BIOTECHNOLOGY INC63909J108COM1,500,000$9,210,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM185,000$8,882,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM65,000$8,720,000thousands by filing date
MEDAVAIL HOLDINGS INC58406B103COM2,920,780$8,529,000thousands by filing date
RAPID MICRO BIOSYSTEMS INC75340L104CLASS A COM437,960$8,089,000thousands by filing date
SIGHT SCIENCES INC82657M105COMMON STOCK342,304$7,770,000thousands by filing date
MACROGENICS INC556099109COM365,000$7,643,000thousands by filing date
INVITAE CORP46185L103COM199,900$5,683,000thousands by filing date
CYTEIR THERAPEUTICS INC23284P103COMMON319,538$5,608,000thousands by filing date
AMYRIS INC03236M200COM NEW352,445$4,839,000thousands by filing date
LEAP THERAPEUTICS INC52187K101COM1,200,000$4,812,000thousands by filing date
IVERIC BIO INC46583P102COM250,000$4,060,000thousands by filing date
BERKELEY LTS INC084310101COM201,996$3,951,000thousands by filing date
ADICET BIO INC007002108COM425,000$3,332,000thousands by filing date
BOLT BIOTHERAPEUTICS INC097702104COM257,267$3,254,000thousands by filing date
VERVE THERAPEUTICS INC92539P101COM15,000$705,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-21-015123this filing2021-11-15acceptance time not in the bulk data set